BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 41997)

  • 1. Dopamine receptors in bovine retina : characterization of the 3H-spiroperidol binding and its use for screening dopamine receptor affinity of drugs.
    Magistretti PJ; Schorderet M
    Life Sci; 1979 Nov; 25(19):1675-86. PubMed ID: 41997
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site.
    Beart PM; Krstich M; McDonald D; Gundlach AL
    Neurosci Lett; 1982 Apr; 29(2):147-51. PubMed ID: 6123968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptors in the goldfish retina: 3H-spiroperidol and 3H-domperidone binding; and dopamine-stimulated adenylate cyclase activity.
    Redburn DA; Clement-Cormier Y; Lam DM
    Life Sci; 1980 Jul; 27(1):23-31. PubMed ID: 6105607
    [No Abstract]   [Full Text] [Related]  

  • 5. [The affinity of aromatic fluoride derivatives of phenothiazine neuroleptics to spiroperidol binding sites of dopamine receptors by the radioligand technic in vitro].
    Oelssner W; Peinhardt G; Büge A
    Pharmazie; 1985 May; 40(5):341-2. PubMed ID: 2863832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the binding of [3H]spiperone and [3H]domperidone in homogenates of mammalian retina and caudate nucleus.
    Watling KJ; Iversen LL
    J Neurochem; 1981 Nov; 37(5):1130-43. PubMed ID: 7299392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]Spiroperidol (spiperone) binding to a putative dopamine receptor in sheep and steer pituitary and stalk median eminence.
    Cronin MJ; Weiner RI
    Endocrinology; 1979 Feb; 104(2):307-12. PubMed ID: 446362
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
    Tachizawa H; Sudo K; Sano M
    Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubilization and characterization of 3H-spiroperidol binding sites of calf caudate.
    Lerner MH; Rosengarten H; Friedhoff AJ
    Life Sci; 1981 Dec; 29(23):2367-74. PubMed ID: 6172690
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging.
    Thal LJ; Horowitz SG; Dvorkin B; Makman MH
    Brain Res; 1980 Jun; 192(1):185-94. PubMed ID: 7378779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
    Near JA; Mahler HR
    J Neurochem; 1981 Mar; 36(3):1142-51. PubMed ID: 7205263
    [No Abstract]   [Full Text] [Related]  

  • 13. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL; Largent BL; Snyder SH
    Life Sci; 1984 Nov; 35(19):1981-8. PubMed ID: 6149442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 3H-spiroperidol binding by an endogenous material from brain.
    Lahti RA; Gay DD; Barsuhn C
    Eur J Pharmacol; 1978 Dec; 53(1):117-8. PubMed ID: 738355
    [No Abstract]   [Full Text] [Related]  

  • 15. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
    Titeler M
    Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
    [No Abstract]   [Full Text] [Related]  

  • 16. A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperone.
    Hartley EJ; Spuhler K; Prasad KN; Seeman P
    Brain Res; 1980 May; 190(2):574-7. PubMed ID: 6154511
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex.
    Marchais D; Tassin JP; Bockaert J
    Brain Res; 1980 Feb; 183(1):235-40. PubMed ID: 7357406
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation by cations of [3H]spiroperidol binding associated with dopamine receptors of rat brain.
    Usdin TB; Creese I; Snyder SH
    J Neurochem; 1980 Mar; 34(3):669-76. PubMed ID: 6766497
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.